Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma
患者来源的异种移植和体外模型表明，甲磺酸伊马替尼在 HEY1-NCoA2 驱动的间充质软骨肉瘤中的再利用是合理的
期刊:Laboratory Investigation
影响因子:5.1
doi:10.1038/s41374-021-00704-4
Polona Safaric Tepes #, Danilo Segovia, Sania Jevtic, Daniel Ramirez, Scott K Lyons, Raffaella Sordella #
